Table 3. Relation between clinicopathological factors and TCF-4J and K expression in patients.
Group | No | TCF-4J | TCF-4K | |||
Level | P value | Level | P value | |||
Age (y) | ≤56 | 23 | 1.00±0.38 | 0.2764 | 0.22±0.23 | 0.1798 |
57≤ | 24 | 0.88±0.38 | 0.31±0.21 | |||
Gender | M | 35 | 0.93±0.41 | 0.8270 | 0.27±0.22 | 0.9107 |
F | 12 | 0.96±0.27 | 0.26±0.24 | |||
Virus | HBV | 29 | 0.98±0.40 | 0.1991 | 0.23±0.22 | 0.1331 |
HCV | 17 | 0.83±0.34 | 0.33±0.21 | |||
Tumorsize (mm) | ≤30 | 17 | 0.83±0.28 | 0.1446 | 0.35±0.19 | 0.0481 |
30< | 30 | 1.00±0.42 | 0.22±0.23 | |||
Vascularinvasion | − | 36 | 0.88±0.35 | 0.0521 | 0.28±0.21 | 0.3975 |
+ | 11 | 1.13±0.41 | 0.21±0.26 | |||
Histology | WD, MD | 29 | 0.82±0.35 | 0.0083 | 0.35±0.18 | 0.0001 |
PD | 18 | 1.12±0.36 | 0.12±0.21 | |||
Liverbackground | Normal, CH | 24 | 0.98±0.40 | 0.3997 | 0.26±0.23 | 0.9985 |
LC | 23 | 0.89±0.36 | 0.26±0.22 |
Abbreviations: CH, chronic hepatitis; HBV, hepatitis B virus; HCV, hepatitis C virus; LC, liver cirrhosis; MD, moderately differentiated; PD, poorly differentiated; WD, well differentiated.